Synthetic Biologics Inc (SYN.A)
SYN.A on American Stock Exchange
1.74USD
18 Jun 2013
1.74USD
18 Jun 2013
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$1.74
$1.74
Open
$1.73
$1.73
Day's High
$1.74
$1.74
Day's Low
$1.68
$1.68
Volume
23,638
23,638
Avg. Vol
7,663
7,663
52-wk High
$2.53
$2.53
52-wk Low
$1.34
$1.34
About
Synthetic Biologics, Inc., formerly Adeona Pharmaceuticals, Inc., is a biotechnology company focused on the development of synthetic deoxyribonucleic acid (DNA)-based therapeutics and disease-modifying medicines for serious illnesses. Its initial synthetic biologic product candidate is intended to treat pulmonary arterial... (more)
Overall
| Beta: | 1.90 |
| Market Cap (Mil.): | $77.70 |
| Shares Outstanding (Mil.): | 44.65 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| SYN.A | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 40.13 | 30.65 |
| EPS (TTM): | -0.45 | -- | -- |
| ROI: | -182.15 | 2.36 | 18.83 |
| ROE: | -182.15 | 3.58 | 19.74 |
Competitors
| Price | Change | |
|---|---|---|
| Incyte Corporation (INCY.OQ) | $20.36 | -1.05 |
| Chelsea Therapeutics International Ltd. (CHTP.OQ) | $2.29 | -0.16 |
| GlaxoSmithKline plc (GSK.L) | 1,665.00p | -11.00 |
| Alcon, Inc. (ACL.N) | -- | -- |
| Shire PLC (SHP.L) | 2,086.00p | -1.00 |
| Shire PLC (3159084.L) | -- | -- |
| Merck & Co., Inc. (MRK.N) | $47.58 | -0.17 |
| Eli Lilly & Co. (LLY.N) | $51.37 | -0.98 |
| Biogen Idec Inc. (BIIB.OQ) | $203.80 | -7.00 |
| Achillion Pharmaceuticals, Inc. (ACHN.OQ) | $8.13 | +0.12 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

